Literature DB >> 3113978

The role of L3T4+ cells in the pathogenesis of lupus in lpr-bearing mice. I. Defects in the production of interleukins 2 and 3.

T J Santoro, K R Lehmann, R A Batt, B L Kotzin.   

Abstract

Mice which bear the lpr gene spontaneously develop autoimmune syndromes characterized by massive expansion of an unusual T cell subset which is phenotypically Thy-1+, L3T4-, Lyt-2-, B220+. The mutant T cells are refractory to stimulation with mitogenic lectins and, by implication, are thought to be solely responsible for the defects in lymphokine production manifested by lpr mice. The contribution of the remaining L3T4+ T cell subset to the latter derangements has not been previously examined and is the focus of this study. We found that abnormalities in concanavalin A-induced interleukin 2 and 3 production in the spleens of MRL-lpr/lpr and C57BL/6.lpr mice occurred in the presence of limited infiltration with B220+, L3T4- T cells. Mixing experiments indicated that B220+ T cells were not suppressive. Furthermore, lpr spleen cells enriched for L3T4+ cells and depleted of sIg+, B220+ and Lyt-2+ cells demonstrated reductions in lymphokine production which were comparable to those seen in unfractionated preparations. Spleen cells from C57BL/6.lpr mice, enriched for L3T4+ cells, were also markedly impaired in a mixed leukocyte reaction in response to stimulator cells from the class II major histocompatibility complex mutant bm12. The results indicate that the aberrations in lymphokine production and proliferation in the spleen cells of lpr mice involve not only B220+ T cells but also L3T4+ cells and suggest a potential role for the L3T4+ subset in the pathogenesis of lupus in lpr-bearing mice.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3113978     DOI: 10.1002/eji.1830170809

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  A new T cell subset expressing B220 and CD4 in lpr mice: defects in the response to mitogens and in the production of IL-2.

Authors:  T Asano; S Tomooka; B A Serushago; K Himeno; K Nomoto
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

Review 2.  The role of cytokines in the immunopathogenesis of lupus.

Authors:  B S Handwerger; V Rus; L da Silva; C S Via
Journal:  Springer Semin Immunopathol       Date:  1994

3.  Effect of cyclophosphamide on lymphokine production in MRL/lpr.Yaa mice.

Authors:  H Kamada; Y Takaoka; K Kitagaki; H Nagai
Journal:  Inflamm Res       Date:  1995-11       Impact factor: 4.575

4.  Subpopulations of CD4+ cells in lpr/lpr mice: differences in expression of T cell receptor/CD3 complex and proliferative responses.

Authors:  T Asano; Y Yoshikai; K Matsumoto; G Matuzaki; K Nomoto
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

5.  Expression and sequences of T cell receptor beta-chain variable genes in the enlarged lymph nodes of C57BL/6-lpr/lpr mice.

Authors:  S Ohga; Y Yoshikai; K Kishihara; G Matsuzaki; T Asano; K Nomoto
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

6.  Photodynamic therapy; a comparison with other immunomodulatory treatments of adjuvant-enhanced arthritis in MRL-lpr mice.

Authors:  L G Ratkay; R K Chowdhary; H C Neyndorff; J Tonzetich; J D Waterfield; J G Levy
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

7.  Incorporation, distribution, and turnover of arachidonic acid within membrane phospholipids of B220+ T cells from autoimmune-prone MRL-lpr/lpr mice.

Authors:  M Tomita-Yamaguchi; J F Babich; R C Baker; T J Santoro
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

8.  The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice.

Authors:  T J Santoro; J P Portanova; B L Kotzin
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

9.  Arachidonoyl-phospholipid remodeling in proliferating murine T cells.

Authors:  Michiyo Tomita; Rodney C Baker; Soichiro Ando; Thomas J Santoro
Journal:  Lipids Health Dis       Date:  2004-01-30       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.